SHEN, QIANWEI
 Distribuzione geografica
Continente #
EU - Europa 322
NA - Nord America 266
AS - Asia 55
Totale 643
Nazione #
PL - Polonia 260
US - Stati Uniti d'America 260
IT - Italia 34
CN - Cina 31
VN - Vietnam 10
SG - Singapore 9
UA - Ucraina 8
CA - Canada 5
DE - Germania 4
SE - Svezia 4
FR - Francia 3
GB - Regno Unito 3
TR - Turchia 3
FI - Finlandia 2
IE - Irlanda 2
CZ - Repubblica Ceca 1
IL - Israele 1
IN - India 1
PA - Panama 1
RU - Federazione Russa 1
Totale 643
Città #
Warsaw 260
Fairfield 38
Woodbridge 23
Ashburn 21
Jacksonville 20
Seattle 20
Cambridge 16
Boardman 13
Houston 13
Wilmington 12
Dong Ket 10
Chandler 8
Nanjing 6
Singapore 6
Ann Arbor 5
Centro 5
Shanghai 5
Toronto 5
Lawrence 4
Princeton 4
San Diego 4
Camerino 3
Guangzhou 3
Istanbul 3
Jinan 3
San Mateo 3
Dublin 2
Helsinki 2
Kilburn 2
L’Aquila 2
New York 2
Ogden 2
Pescara 2
Phoenix 2
Wuhan 2
Zhengzhou 2
Ascoli Piceno 1
Augusta 1
Beijing 1
Brno 1
Buti 1
Cesena 1
Fano 1
Genova 1
Hangzhou 1
Hebei 1
Jinhua 1
La Canada Flintridge 1
Lanzhou 1
Mumbai 1
Palma Campania 1
Shenyang 1
Tel Aviv 1
Tianjin 1
Verona 1
Yiwu 1
Totale 553
Nome #
Buprenorphine requires concomitant activation of NOP and MOP receptors to reduce cocaine consumption 267
Cebranopadol, a Mixed Opioid Agonist, Reduces Cocaine Self-administration through Nociceptin Opioid and Mu Opioid Receptors 243
NOP receptor agonist RO 64-6198 decreases escalation of cocaine self-administration in rats genetically selected for alcohol preference 109
Selective inhibition of phosphodiesterase 7 enzymes reduces motivation for nicotine use through modulation of mesolimbic dopaminergic transmission 31
Cebranopadol, a novel long-acting opioid agonist with low abuse liability, to treat opioid use disorder: Preclinical evidence of efficacy 12
Totale 662
Categoria #
all - tutte 2.488
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.488


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202094 0 0 0 0 14 8 6 15 14 11 10 16
2020/2021211 15 19 40 16 21 21 17 7 18 13 10 14
2021/202236 5 6 3 0 1 3 0 2 1 3 8 4
2022/202336 8 2 3 1 0 1 1 3 4 2 5 6
2023/202441 5 2 6 5 1 2 3 0 4 0 4 9
2024/202544 11 2 14 8 9 0 0 0 0 0 0 0
Totale 662